Published in Am J Med Genet on April 01, 1984
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
Turnover mechanisms of the stable yeast PGK1 mRNA. Mol Cell Biol (1995) 5.83
Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations. JAMA (1998) 2.58
Parthenogenic origin of benign ovarian teratomas. N Engl J Med (1975) 2.53
Congenital contractural arachnodactyly. A heritable disorder of connective tissue. J Bone Joint Surg Am (1971) 2.24
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (1984) 1.98
Heritable fragile site on chromosome 16: probable localization of haptoglobin locus in man. Science (1970) 1.87
Trisomy 13 (D1) syndrome: studies on parental age, sex ratio, and survival. J Pediatr (1968) 1.84
Ring-G chromosome, a new G-deletion syndrome? Am J Dis Child (1968) 1.84
Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet (1993) 1.72
Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci U S A (1975) 1.61
Not all chromosome imbalance resulting from the 11q;22q translocation is due to 3:1 segregation in first meiosis. Hum Genet (1989) 1.60
The importance of being a fragile site. Am J Hum Genet (1979) 1.57
XXY cells in a predominantly XX human male: evidence for cell selection. Pediatrics (1966) 1.51
Non-random occurrence of 7-14 translocations in human lymphocyte cultures. Nature (1975) 1.41
"New" syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896. Pediatrics (1972) 1.40
Estimating distances from the centromere by means of benign ovarian teratomas in man. Ann Hum Genet (1976) 1.40
Seizure disorders in the fragile X chromosome syndrome. Am J Med Genet (1991) 1.39
Trypanosoma brucei mitochondrial guide RNA-mRNA chimera-forming activity cofractionates with an editing-domain-specific endonuclease and RNA ligase and is mimicked by heterologous nuclease and RNA ligase. Mol Cell Biol (1995) 1.36
Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature (1987) 1.35
Mechanisms of giemsa banding of chromosomes. I. Giemsa-11 banding with azure and eosin. Exp Cell Res (1976) 1.33
Gene for incontinentia pigmenti maps to band Xp11 with an (X;10) (p11;q22) translocation. Clin Genet (1987) 1.33
Hereditary dysplasia of bone with kyphoscoliosis, contractures, and abnormally shaped ears. J Pediatr (1968) 1.30
Partial trisomy 15. Lancet (1972) 1.29
Long-term growth of malignant thymocytes in vitro. Blood (1989) 1.28
The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell (2001) 1.27
Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet (1984) 1.22
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science (1986) 1.21
Editing domains of Trypanosoma brucei mitochondrial RNAs identified by secondary structure. Mol Cell Biol (1995) 1.21
Histiocytic lymphoma cell lines: immunologic and cytogenetic studies. Cancer Genet Cytogenet (1985) 1.21
A surgical approach to the treatment of fetal hydrocephalus. N Engl J Med (1982) 1.18
Nonrandomness of translocations in man: preferential entry of chromosomes into 13-15-21 translocations. Science (1968) 1.17
Chromosome 3 duplication q/deletion p syndrome. Pediatrics (1978) 1.17
Ataxia-telangiectasia--clonal growth of translocation lymphocytes. N Engl J Med (1973) 1.17
Increased frequency of thyroid autoantibodies in mothers of patients with Down's syndrome. Lancet (1965) 1.14
Heritable dysmorphic syndrome with normal intelligence. J Pediatr (1967) 1.13
The Interregional Cytogenetic Register System (ICRS). Birth Defects Orig Artic Ser (1978) 1.13
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma. Blood (1986) 1.11
Rare, polymorphic, and common fragile sites: a classification. Hum Genet (1986) 1.11
What we don't know about genetic counseling. N Engl J Med (1972) 1.09
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood (1988) 1.09
Lysergic-acid-diethylamide and cannabis as possible teratogens in man. Lancet (1968) 1.08
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer (1997) 1.08
Little heads: inheritance and early detection. J Pediatr (1979) 1.07
Three additional cases of the congenital hypothalamic "hamartoblastoma" (Pallister-Hall) syndrome. Am J Med Genet (1989) 1.06
Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res (1995) 1.06
Fragile sites and cancer breakpoints. Cancer Genet Cytogenet (1984) 1.05
Patterns of D chromosome involvement in human (DqDq) and (DqGq) Robertsonian rearrangements. Am J Hum Genet (1971) 1.04
Tort liability in genetic diagnosis and genetic counseling. Am J Hum Genet (1982) 1.04
A rearranged transforming gene, tre, is made up of human sequences derived from chromosome regions 5q, 17q and 18q. Oncogene (1988) 1.04
Double aneuploidy: the frequency of XXY in males with Down's syndrome. Am J Hum Genet (1969) 1.04
Congenital cutis laxa with retardation of growth and motor development: a recessive disorder of connective tissue with male lethality. Clin Genet (1986) 1.04
Neurofibromatosis and malignancy. J Pediatr (1979) 1.02
Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Curr Opin Chem Biol (2001) 1.01
Annotation: genetic effects of aneuploidy. Am J Hum Genet (1973) 1.00
Identification by fluorescence of two G rings: (46,XY,21r) G deletion syndrome I and (46, XX, 22r) G deletion syndrome II. Ann Genet (1972) 1.00
Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose- and time-response curves and relation to cellular immunity. Int Arch Allergy Appl Immunol (1970) 0.99
Familial predisposition to thyroid disease in Down's syndrome: controlled immunoclinical studies. Am J Hum Genet (1971) 0.99
IgA and partial deletions of chromosome 18. Lancet (1969) 0.98
Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet (1988) 0.98
A confirmatory factor analysis of the WISC-III in a clinical sample with cross-validation in the standardization sample. Child Neuropsychol (2001) 0.96
Human benign ovarian teratomas: chromosomal and electrophoretic enzyme studies. Birth Defects Orig Artic Ser (1978) 0.95
Mosaicism with translocation: autoradiographic and fluorescent studies of an inherited reciprocal translocation t(2q+;14q-). J Med Genet (1972) 0.95
Chromosome subband 17p11.2 deletion: a minute deletion syndrome. J Med Genet (1988) 0.95
Nomenclature: the Philadelphia chromosome or Ph without superscript. Cancer Genet Cytogenet (1985) 0.95
Acute myeloblastic leukemia (AML) with t(6;9) (p23;q34): a specific subgroup of AML? Cancer Genet Cytogenet (1983) 0.94
Ovarian teratomas: cytologic data. Cytogenet Cell Genet (1976) 0.94
Study of a patient with apparent monosomy 21 owing to translocation: 45,XX,21-,t(18q+). Cytogenetics (1971) 0.94
Xq- Turner's syndrome: reconsideration of hypothesis that Xp- causes somatic features in Turner's syndrome. J Med Genet (1970) 0.94
Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet (1990) 0.93
Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. Cancer Genet Cytogenet (1981) 0.92
Telomeric fusion in pre-T-cell acute lymphoblastic leukemia. Hum Genet (1986) 0.92
Amniocyte clones for prenatal cytogenetics. Am J Med Genet (1981) 0.92
Racial differences in the frequency of Q and C chromosomal heteromorphisms. Nature (1977) 0.92
Mosaicism in Turner's syndrome reflects the lethality of XO. Lancet (1969) 0.90
Fragile sites limited to lymphocytes: molecular recombination and malignancy. Cancer Genet Cytogenet (1987) 0.89
Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet (1986) 0.89
Ovarian teratomas and genetics of germ-cell formation. Lancet (1976) 0.89
The half chromatid mutation model and bidirectional mutation in incontinentia pigmenti. Clin Genet (1983) 0.89
Y chromosome--specific DNA sequences in Turner-syndrome mosaicism. Am J Hum Genet (1987) 0.89
Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet (1994) 0.88
Fragile sites and chromosome breakpoints in constitutional rearrangements I. Amniocentesis. Clin Genet (1984) 0.88
Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement. Cancer Res (1988) 0.88
Translocations in T-cell leukemia in lymphoma. N Engl J Med (1985) 0.88
Linkage relationships of 1qh to Amy, Fy, PGM1, and Rh. Birth Defects Orig Artic Ser (1975) 0.88